Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Rats to a burger joint dumpster : Why does Florida have such awful politicians ?
30/06/2025
Knee-jerk Trump attack reveals opponent he truly fears : analyst
30/06/2025
'Vulnerable' : New alarm as Musk's 'God tier access' to damaging data revealed
30/06/2025
'Diplomatic fumble' is crippling Trump's best chance at trade deal : report
30/06/2025
